| |
Hazard ratio
|
SE
|
p-value
|
95% CI
|
|---|
|
IGF2BP3
|
3.343
|
1.931
|
0.051
|
1.921 - 8.963
|
|
Age
|
1.032
|
0.017
|
0.673
|
1.002 - 1.0681
|
|
AJCC
| | | | |
|
IA
|
2.21e - 13
|
4.38e - 06
|
1.000
|
0
|
|
IB
|
4.377
|
4.292
|
0.126
|
0.661 - 28.991
|
|
IIA
|
2.496
|
1.754
|
0.226
|
0.571 - 10.873
|
|
IIB
|
2.152
|
1.413
|
0.257
|
0.096 - 3.462
|
|
III
|
2.564
|
2.034
|
0.248
|
0.523 - 7.639
|
|
IV
|
1.76e - 09
|
3.84e-07
|
1.000
|
0
|
|
LVI
|
1.876
|
0.862
|
0.506
|
0.203-5.476
|
|
WHO
| | | | |
|
1
|
0.704
|
0.431
|
0.563
|
0.214-2.335
|
|
2
|
0.651
|
0.429
|
0.510
|
0.187-2.371
|
|
3
|
0.582
|
0.527
|
0.554
|
0.099-3.627
|
|
PNI
|
1.456
|
0.873
|
0.738
|
0.411-3.452
|
- SE - standard error, LVI - lymphovascular invasion, PNI - perineural invasion
